QS-21 and QS-7: purified saponin adjuvants.

Developments in biological standardization

Volumn 92, Issue , 1998, Pages 41-47

  Kensil, C R ^a   Wu, J Y ^a   Anderson, C A ^a   Wheeler, D A ^a   Amsden, J ^a  

^a Aquila Biopharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; GLYCOPROTEIN GP 120; IMMUNOLOGICAL ADJUVANT; OLEANOLIC ACID; OVALBUMIN; QS 21; QS 7; RECOMBINANT PROTEIN; SAPONIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMICAL MODEL; CYTOTOXIC T LYMPHOCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; MOUSE; QUILLAJA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HIV ENVELOPE PROTEIN GP120; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, CHEMICAL; OLEANOLIC ACID; OVALBUMIN; QUILLAJA; RECOMBINANT PROTEINS; SAPONINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031626756     PISSN: 03015149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)